These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17893562)

  • 21. CD154-CD40 interactions are essential for thymus-dependent antibody production in zebrafish: insights into the origin of costimulatory pathway in helper T cell-regulated adaptive immunity in early vertebrates.
    Gong YF; Xiang LX; Shao JZ
    J Immunol; 2009 Jun; 182(12):7749-62. PubMed ID: 19494299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells.
    Gomes EM; Rodrigues MS; Phadke AP; Butcher LD; Starling C; Chen S; Chang D; Hernandez-Alcoceba R; Newman JT; Stone MJ; Tong AW
    Clin Cancer Res; 2009 Feb; 15(4):1317-25. PubMed ID: 19228733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nuclear factor-kappaB inhibitor BAY11-7082 inhibits interactions between human endothelial cells, T cells, and monocytes.
    Zhu B; Liu Z; Wang P; Wu C; Xu H
    Transplant Proc; 2008 Oct; 40(8):2724-8. PubMed ID: 18929846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
    Wang P; Liu Z; Wu C; Zhu B; Wang Y; Xu H
    Transplant Proc; 2008 Oct; 40(8):2729-33. PubMed ID: 18929847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease.
    Howard LM; Miller SD
    Autoimmunity; 2004 Aug; 37(5):411-8. PubMed ID: 15621565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between hepatic immunoglobulin production and CD154 expression in chronic liver diseases.
    Mayo MJ; Mosby JM; Jeyarajah R; Combes B; Khilnani S; Al-halimi M; Handem I; Grammer AC; Lipsky PE
    Liver Int; 2006 Mar; 26(2):187-96. PubMed ID: 16448457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects on carcinomas.
    Vardouli L; Lindqvist C; Vlahou K; Loskog AS; Eliopoulos AG
    Cancer Gene Ther; 2009 Nov; 16(11):848-60. PubMed ID: 19461675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia.
    Wierda WG; Cantwell MJ; Woods SJ; Rassenti LZ; Prussak CE; Kipps TJ
    Blood; 2000 Nov; 96(9):2917-24. PubMed ID: 11049967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble CD40 and its ligand CD154 in patients with Graves' ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy.
    Myśliwiec J; Waligórski D; Nikołajuk A; Górska M
    Adv Med Sci; 2007; 52():104-8. PubMed ID: 18217399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD40 is required for development of islet inflammation in the RIP-CD154 transgenic mouse model of type 1 diabetes.
    Haase C; Markholst H
    Ann N Y Acad Sci; 2007 Jun; 1107():373-9. PubMed ID: 17804565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD154 Resistant to Cleavage from Intracellular Milieu and Cell Surface Induces More Potent CD40-Mediated Responses.
    Salti S; Al-Zoobi L; Darif Y; Hassan GS; Mourad W
    J Immunol; 2021 Apr; 206(8):1793-1805. PubMed ID: 33762325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD154 and its receptors in inflammatory vascular pathologies.
    Hassan GS; Merhi Y; Mourad WM
    Trends Immunol; 2009 Apr; 30(4):165-72. PubMed ID: 19282242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
    Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of functional CD154 (CD40 ligand) in the Pekin duck.
    Fischer KP; Gares SL; Wang D; Lorne Tyrrell D; Gutfreund KS
    Dev Comp Immunol; 2007; 31(1):61-71. PubMed ID: 16837046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal Antibody Targeting the CD154 Cleavage Site Inhibits CD40-Dependent and -Independent Cleavage of CD154 from the Cell Surface.
    Salti S; Al-Zoobi L; Darif Y; Hassan GS; Mourad W
    Immunohorizons; 2021 Jul; 5(7):590-601. PubMed ID: 34326200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.
    Henn V; Steinbach S; Büchner K; Presek P; Kroczek RA
    Blood; 2001 Aug; 98(4):1047-54. PubMed ID: 11493450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet influence on T- and B-cell responses.
    Sowa JM; Crist SA; Ratliff TL; Elzey BD
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):235-41. PubMed ID: 19578816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation.
    Ashokkumar C; Gupta A; Sun Q; Ningappa MB; Higgs BW; Mazariegos G; Fazzolare T; Remaley L; Soltys K; Bond G; Abu-Elmagd K; Sindhi R
    Surgery; 2009 Aug; 146(2):166-73. PubMed ID: 19628070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis.
    Engel D; Seijkens T; Poggi M; Sanati M; Thevissen L; Beckers L; Wijnands E; Lievens D; Lutgens E
    Semin Immunol; 2009 Oct; 21(5):308-12. PubMed ID: 19616449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
    Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.